Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Pleural disease is a common presentation and spans a heterogeneous population across
broad disease entities; a common feature is the requirement for interventional procedures …

A total of 21 659 pleural aspirations or drain insertions were conducted in England in
2019/2020 with a combined cost of£ 13.4 million. 1 There are now a variety of different …

Malignant pleural effusion (MPE) is a common condition which often causes significant
symptoms to patients and costs to healthcare systems. Over the past decade, the …

With no cure for malignant pleural effusion, efforts are focused on symptomatic
management. Historically, this symptomatic management was achieved with the instillation …

Background Thoracentesis using suction is perceived to have increased risk of
complications, including pneumothorax and re-expansion pulmonary oedema (REPO) …

Malignant pleural disease represents a growing healthcare burden. Malignant pleural
effusion affects approximately 1 million people globally per year, causes disabling …

Hepatic hydrothorax can be present in 5% to 15% of patients with underlying cirrhosis and
portal hypertension, often reflecting advanced liver disease. Its impact can be variable …

Background: Non-expandable lung (NEL) has severe implications for patient symptoms and
impaired lung function, as well as crucial implications for the management of malignant …

Pleural disease diagnostics represent a sprawling topic that has enjoyed a renaissance in
recent years from humble beginnings. Whilst pleural patients are heterogeneous as a …